Comparison of 11C-Methionine, 11C-Choline, and 18F-Fluorodeoxyglucose-PET for Distinguishing Glioma Recurrence from Radiation Necrosis
スポンサーリンク
概要
- 論文の詳細を見る
The aim of this study is to assess the different metabolic activities characteristic of glioma recurrence and radiation necrosis (RN) and to explore the diagnostic accuracy for differentiation of the two conditions using 11C-methionine (MET), 11C-choline (CHO), and 18F-fluorodeoxyglucose (FDG)-positron emission tomography (PET). Fifty patients with lesions suggestive of recurrent glioma by MRI underwent MET, CHO, and FDG-PET. All patients who had previously been treated with radiotherapy for malignant glioma were subjected to open surgery and pathological diagnosis (17 recurrent grade 3- gliomas (Gr.3s) comprising 7 anaplastic astrocytomas (AAs) and 10 anaplastic oligodendrogliomas (AOs), 17 recurrent glioblastomas (Gr.4s), and 16 RNs). We measured the PET/Gd volume ratio, the PET/Gd overlap ratio, and the lesion/normal brain uptake ratio (L/N ratio) and determined the optimal index of each PET scan. The PET/Gd volume ratio and the PET/Gd overlap ratio for RN were significantly lower than those of glioma recurrence only with MET-PET (P < 0.05). The L/N ratio of RN was significantly lower than that of Gr.4 with all PET imaging (P < 0.001) and was significantly lower than that of Gr.3, especially for AO, only with MET-PET images (P < 0.005). Receiver operating characteristic (ROC) analysis showed that the area under the curve of MET, CHO, and FDG was 92.5, 81.4, and 77.4, respectively. MET L/N ratio of greater than 2.51 provided the best sensitivity and specificity for establishing glioma recurrence (91.2% and 87.5%, respectively). These results demonstrated that MET-PET was superior to both CHO and FDG-PET for diagnostic accuracy in distinguishing glioma recurrence from RN.
- 社団法人 日本脳神経外科学会の論文
著者
-
Iwama Toru
Department Of Cardiology Tokyo Metropolitan Bokutoh General Hospital
-
Yano Hirohito
Department Of Neurosurgery Daiyukai General Hospital
-
TAKENAKA Shunsuke
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
-
ASANO Yoshitaka
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
-
SHINODA Jun
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
-
NOMURA Yuichi
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
-
YONEZAWA Shingo
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
-
MIWA Kazuhiro
Chubu Medical Center for Prolonged Traumatic Brain Dysfunction, Kizawa Memorial Hospital
関連論文
- Convulsion During Intra-arterial Infusion of Fasudil Hydrochloride for the Treatment of Cerebral Vasospasm Following Subarachnoid Hemorrhage
- Hemispheric Laminar Necrosis as a Complication of Traumatic Carotid-Cavernous Sinus Fistula
- Brain Tumor Stem Cells From an Adenoid Glioblastoma Multiforme
- FRS-180 Multi-Center Experience of IVUS-Guided Rotastent with Lower B/A Ratio for Calcified Coronary Leions with Large Target Reference(≥4.0mm)(Percutaneous Coronary Intervention (IHD) : FRS21)(Featured Research Session (English))
- PE-206 Multi-center Experience and Favorable Long-term Prognosis of Cypher DES in Treating Small Coronary Arteries (≤3.0mm diameter) Compared with Bx Velocity Stents(Coronary revascularization, PCI-12 (IHD) PE35,Poster Session (English),The 70th Annive
- OJ-101 Multi-Center Comprehensive Analysis for Two Major Complications of Cypher : Ticlopidine Induced Liver Dysfunction and Subacute Thrombosis(Coronary revascularization, PCI-5 (IHD) OJ17,Oral Presentation (Japanese),The 70th Anniversary Annual Scientif
- OE-225 A Multi-Center High Volume Registry Analysis (>4,000) of Cypher DBS in Japan; Procedural/Clinical Success and Prognosis by Experienced Operatots(Coronary revascularization, PCI-2 (IHD) OE38,Oral Presentation (English),The 70th Anniversary Annual Sc
- Significant Effect to Reduce Restenosis by Cypher DES Compared to Velocity Stents After Rotablator in Hemodialysis Patients. A Multi-Center Experience(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 17 (IHD), The 69th Annual Scientific Me
- Review of Safety and Effectiveness of Ticlopidine Use for Cypher Drug Eluting Stents(DES) : A Multi-Center Analysis in Japan(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 10 (IHD), The 69th Annual Scientific Meeting of the Japanese Circ
- Japanese Multi-Center Experience with Favorable Initial Success Rates and Striking 90days Follow-up Results for Cypher Drug Eluting Stent (DES)(Coronary Revascularization, PTCA/Stent/DCA/Rotablator/New Device 16 (IHD), The 69th Annual Scientific Meeting o